Lv1
100 积分 2021-12-06 加入
First-Line Pembrolizumab Plus Chemotherapy for Advanced Biliary Tract Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-966 Study
8天前
已完结
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population
8天前
已完结
Impact of the Interval between Transarterial Chemoembolization Sessions on Survival in Patients with Unresectable Hepatocellular Carcinoma
13天前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
14天前
已完结
BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update
20天前
已完结
TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells
22天前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
23天前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
29天前
已完结
Calcium Movements, Distribution, and Functions in Smooth Muscle
1个月前
已完结
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
1个月前
已完结
皖公网安备34019202002308
